nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Distinguishing the Vaccine Effectiveness of Inactivated BBIBP-CorV Vaccine Booster Against the Susceptibility, Infectiousness, and Transmission of Omicron Stains: A Retrospective Cohort Study in Urumqi, China
|
Zeng, Ting |
|
|
12 |
10 |
p. 2405-2416 |
artikel |
2 |
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
|
Piemonti, Lorenzo |
|
|
12 |
10 |
p. 2437-2456 |
artikel |
3 |
Pharmacokinetics and Safety of Ainuovirine/Lamivudine/Tenofovir Combination Tablets in Young and Elderly Patients with Human Immunodeficiency Virus-1 Infection
|
Xie, Xiaoxin |
|
|
12 |
10 |
p. 2457-2469 |
artikel |
4 |
Prognostic Value of Blood Urea Nitrogen for Short-Term Mortality in Patients with Infective Endocarditis
|
Wang, Qi |
|
|
12 |
10 |
p. 2353-2366 |
artikel |
5 |
Range of Clinical Manifestations Caused by Invasive Meningococcal Disease Due to Serogroup W: A Systematic Review
|
Bertrand-Gerentes, Isabelle |
|
|
12 |
10 |
p. 2337-2351 |
artikel |
6 |
Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study
|
Leegwater, Emiel |
|
|
12 |
10 |
p. 2471-2484 |
artikel |
7 |
Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea
|
Cho, Yuri |
|
|
12 |
10 |
p. 2387-2403 |
artikel |
8 |
Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea
|
Lee, Ji Yeon |
|
|
12 |
10 |
p. 2417-2435 |
artikel |
9 |
Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older
|
Neveu, David |
|
|
12 |
10 |
p. 2367-2386 |
artikel |
10 |
Targeting Dalbavancin Inoculum Effect: Adjunctive Single Dose of Daptomycin
|
Kebriaei, Razieh |
|
|
12 |
10 |
p. 2485-2494 |
artikel |